Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. ARTARAZ (BILBAO, Spain), A. Uranga (BILBAO, Spain), L. Chasco (BILBAO, Spain), P. Garcia (BILBAO, Spain), U. Aguirre (BILBAO, Spain), J. Quintana (BILBAO, Spain), R. Menendez (VALENCIA, Spain), F. Aspa (MADRID, Spain), S. Bello (ZARAGOZA, Spain), P. España (BILBAO, Spain). Role of biomarkers of systemic inflammation in the prediction of mortality and/or severe complications in community adquired pneumonia. 4535

Member's Comments

No comment yet.

Related content which might interest you: Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Prediction of complications development and lethal outcome in patients with community-acquired pneumonia Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Inflammatory responses predict long-term mortality risk in community-acquired pneumonia Source: Eur Respir J 2011; 37: 1439-1446 Year: 2011 Incidence, risk factors and outcomes of nonresolving pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Management-based risk prediction in community-acquired pneumonia by scores and biomarkers Source: Eur Respir J 2013; 41: 974-984 Year: 2013 Risk factors for early onset severe community-acquired pneumonia complications Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ? Year: 2018 The possibility to predict the danger of destabilization development of the ischemic heart disease course in patients with community-acquired pneumonia infected with chlamydophila pneumonia Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Effects of systemic steroids in patients with severe community-acquired pneumonia Source: Eur Respir J 2007; 30: 951-956 Year: 2007 Severe acute malnutrition(SAM) as a predictor of mortality in pediatric community acquired pneumonia Source: International Congress 2019 – Paediatric respiratory infections around the world: Tuberculosis, pneumonia and others Year: 2019 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Importance of cardiac biomarkers in the evaluation of acute pulmonary thromboembolism severity, mortality and complicated clinical course Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011 Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia Source: Eur Respir J 2009; 33: 521 Year: 2009 Potential causes of increased long-term mortality after pneumonia Source: Eur Respir J 2011; 37: 1306-1307 Year: 2011 The influence of chronic concomitant diseases and age on the risk of death in patients with community-aquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002 Intrahospital cardiovascular complications in severe community-acquired pneumonia Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP) Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Reduction of in-hospital mortality in patients with acute exacerbation of interstitial pneumonia recognized after introduction of non-invasive ventilation Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008 Etiology and prognosis factors in severe community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 477s Year: 2002 Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients Source: Eur Respir J 2011; 38: 643-648 Year: 2011